Global Biomarkers Market Size & Outlook, 2023-2030
Global biomarkers market, 2018-2030 (US$M)
Related Markets
Global biomarkers market highlights
- The global biomarkers market generated a revenue of USD 81,043.5 million in 2023 and is expected to reach USD 194,216.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 13.3% by 2030.
- In terms of segment, safety accounted for a revenue of USD 30,492.4 million in 2023.
- Efficacy is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 81,043.5 million |
| Market revenue in 2030 | USD 194,216.8 million |
| Growth rate | 13.3% (CAGR from 2023 to 2030) |
| Largest segment | Safety |
| Fastest growing segment | Efficacy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Safety, Efficacy, Validation |
Other key industry trends
- In terms of revenue, the North America accounted for 43.9% of the global biomarkers market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Germany is the fastest growing regional market and is projected to reach USD 9,340.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarkers Market Scope
Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarkers market will help companies and investors design strategic landscapes.
Safety was the largest segment with a revenue share of 37.62% in 2023. Horizon Databook has segmented the Global biomarkers market based on safety, efficacy, validation covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biomarkers Type Outlook (Revenue, USD Million, 2018-2030)
- Safety
- Efficacy
- Validation
- Global Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Other Application
- Global Biomarkers Disease Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Safety Cancer Disease
- Efficacy Cancer Disease
- Validation Cancer Disease
- Cardiovascular Disease
- Safety Cardiovascular Disease
- Efficacy Cardiovascular Disease
- Validation Cardiovascular Disease
- Neurological Disease
- Safety Neurological Disease
- Efficacy Neurological Disease
- Validation Neurological Disease
- Immunological Disease
- Safety Immunological Disease
- Efficacy Immunological Disease
- Validation Immunological Disease
- Other Disease
- Safety Disease
- Efficacy Disease
- Validation Disease
- Cancer
Reasons to subscribe to Global biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biomarkers market databook
-
Our clientele includes a mix of biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biomarkers market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biomarkers market size, 2023 (US$M)
Global biomarkers market share, by type, 2023 & 2030 (%, US$M)
Biomarkers market: Opportunity assessment by country
Global biomarkers market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
